RxDoctor Payments Data

Ian Baird

Infectious Disease · Columbus, OHNPI 1427034008

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $875 of the $1,006 with a category attached, or 86.9%. Cumberland Pharmaceuticals, Inc. accounts for 86.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $887 and has fallen 93.9% since, to $54 in 2021.

$1,006in general payments, 2019–2025

Across 7 payments — averaging $143.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cumberland Pharmaceuticals, Inc.$875
  • Astellas Pharma US Inc$80
  • GSK$39
  • Merck$13
$808,508in research payments, 2019–2025

Across 73 payments — averaging $11,075 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$467K
  • Pfizer$184K
  • Ironwood Pharmaceuticals, Inc$75K
  • Novartis$68K
  • Biogen$9K
  • Incyte Corporation$7K
  • plus $43 from 1 others

What the payments were for

  • Consulting fees$87587%
  • Food & beverage$394%
  • Education$939%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,006 in reported general payments places this provider in the 70th percentile of 308 infectious disease providers in Ohio.

See all infectious disease providers in Ohio

Other infectious disease in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →